Evangelou Angelos, Toliopoulos Ioannis, Giotis Christos, Metsios Apostolos, Verginadis Ioannis, Simos Yannis, Havelas Konstantinos, Hadziaivazis Georgios, Karkabounas Spyridon
Laboratory of Physiology, University of Ioannina, Greece.
Electromagn Biol Med. 2011 Mar;30(1):46-56. doi: 10.3109/15368378.2011.566776.
The main objective of our study is to investigate whether an enhancement of the immune system in end-stage cancer patients is achieved by exposure to coherent electromagnetic fields. For this reason, 15 end-stage cancer patients were exposed at low intensity, coherent electromagnetic fields at radiofrequencies ranging from 600 kHz-729 Hz, for 8 h/day, 6 days/week for 4 weeks. NKs number and cytotoxicity of NK T-lymphocytes versus K562 cancer cell line were estimated by flow cytometry, before and after exposure. Data showed that the exposure of the end-stage cancer patients to the coherent electromagnetic fields resulted in a significant increase of the number and the cytotoxicity of the NK T-lymphocytes against cancer cells, in all patients. Exposure to coherent EMFs at radiofrequencies increases the number and cytotoxicity of NK T-lymphocytes, which may contribute to the improvement of cancer patients' status.
